# Aligos Therapeutics Inc.

Canonical: https://abierto.us/vendors/aligos-therapeutics-inc-ed19abdrlv29

- UEI: ED19ABDRLV29
- CAGE: 96ED3
- Location: South San Francisco, CA
- Awards in window: 1 (4 transactions), $2,816,916 obligated, March 29, 2024 to June 18, 2025

## Awarding agencies

- National Institutes of Health: 1 awards, $2,816,916

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,816,916

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93023C00052 (definitive contract): $2,816,916, National Institutes of Health Niaid. To Conduct Clinical Development of a Compound for the Treatment of Covid-19.. https://www.usaspending.gov/award/CONT_AWD_75N93023C00052_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/aligos-therapeutics-inc-ed19abdrlv29.